Replies to post #10967 on Aurinia Pharmaceuticals Inc (AUPH)

[zzaatt]

nothing but good news events over the next 6 months

Absolutely! No argument from me.

I read the alpha article, Interesting, but I don't get this:

If we assume AUPH will eventually trade at 3X peak sales

I see valuations in the biotech sector in the 5 to 20 range. I wonder how the author got his number, seems way too low. Also, I would expect that the approval momentum would trigger a more precipitous upward move.